West Pharmaceutical Services, Inc.
WST
$259.79
-$19.62-7.02%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.73% | 9.17% | 0.37% | 2.30% | -0.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.73% | 9.17% | 0.37% | 2.30% | -0.07% |
| Cost of Revenue | 5.83% | 4.34% | 0.19% | 4.69% | 5.03% |
| Gross Profit | 11.18% | 19.09% | 0.74% | -1.62% | -8.19% |
| SG&A Expenses | 23.44% | 13.86% | -0.12% | -8.16% | -7.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -50.00% | -- | 0.00% | -100.00% | 250.00% |
| Total Operating Expenses | 8.38% | 5.92% | -0.09% | 2.30% | 2.85% |
| Operating Income | 5.46% | 23.55% | 2.47% | 2.26% | -9.06% |
| Income Before Tax | 3.33% | 21.62% | -13.52% | -2.68% | -11.69% |
| Income Tax Expenses | 4.94% | 37.90% | 46.95% | 6.67% | 10.20% |
| Earnings from Continuing Operations | 2.94% | 18.42% | -22.12% | -5.04% | -15.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.94% | 18.42% | -22.12% | -5.04% | -15.69% |
| EBIT | 5.46% | 23.55% | 2.47% | 2.26% | -9.06% |
| EBITDA | 5.75% | 19.60% | 4.65% | 4.22% | -5.53% |
| EPS Basic | 3.80% | 19.73% | -21.04% | -3.21% | -13.95% |
| Normalized Basic EPS | 6.65% | 25.25% | 2.21% | 4.40% | -9.37% |
| EPS Diluted | 3.78% | 20.53% | -20.65% | -2.10% | -13.55% |
| Normalized Diluted EPS | 6.94% | 25.92% | 2.62% | 4.80% | -8.90% |
| Average Basic Shares Outstanding | -0.82% | -1.10% | -1.36% | -1.89% | -2.02% |
| Average Diluted Shares Outstanding | -1.09% | -1.63% | -1.75% | -2.27% | -2.52% |
| Dividend Per Share | 5.00% | 5.00% | 5.00% | 5.00% | 5.26% |
| Payout Ratio | 0.01% | -0.13% | 0.33% | 0.09% | 0.23% |